| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/28/2007 | US20070150983 Prevention of Bt resistance development |
| 06/28/2007 | US20070150978 Single nucleotide polymorphism (SNP) and repetitive element markers for use in characterizing phenotypic expression in plants |
| 06/28/2007 | US20070150974 TRANSGENIC NON-HUMAN MAMMAL WITH AN ONCOGENIC MUTANT OF THE c-Raf-1 GENE |
| 06/28/2007 | US20070150973 Genetically engineering cell to regulate expression of gene target via nucleic acid coding fusion protein having transcription regulatory domain and composite DNA binding domain; gene therapy |
| 06/28/2007 | US20070150971 Sequences upstream of the carp gene, vectors containing them and uses thereof |
| 06/28/2007 | US20070150970 Compositions and methods for identifying modulators of transducisomes, a new class of therapeutic targets |
| 06/28/2007 | US20070149770 Poly zinc finger proteins with improved linkers |
| 06/28/2007 | US20070149769 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs) |
| 06/28/2007 | US20070149767 Agent |
| 06/28/2007 | US20070149766 Method for producing a recombinant protein of interest and protein thus produced |
| 06/28/2007 | US20070149765 Liquid phase peptide syntheses of KL-4 pulmonary surfactant |
| 06/28/2007 | US20070149764 Polypeptide having collagen-like structure |
| 06/28/2007 | US20070149762 Block Copolypeptide vesicle based materials for drug delivery |
| 06/28/2007 | US20070149761 To evaluate the effectiveness of a compound to inhibit NS5B activity |
| 06/28/2007 | US20070149565 Nelfinavir conjugates and antibodies useful in immunoassay |
| 06/28/2007 | US20070149475 AUGMENTATION OF WOUND HEALING BY eIF-4E mRNA AND EGF mRNA |
| 06/28/2007 | US20070149467 vascular endothelial growth factor (VEGF); ischemic heart disease |
| 06/28/2007 | US20070149456 Epithelial sodium channel inhibiting agents and uses therefor |
| 06/28/2007 | US20070149455 Modified and stabilized gdf propeptides and uses thereof |
| 06/28/2007 | US20070149453 Treating inflammation using a biological agent that causes cells to release cytokine receptors |
| 06/28/2007 | US20070149450 Method for reducing levels of c-reactive protein |
| 06/28/2007 | US20070149449 Therapeutic targets in cancer |
| 06/28/2007 | US20070149448 chronic ulcers; cytotoxic effect of LL-37 may be reduced by including a bilayer-forming polar lipid, especially a digalactosyldiacylglycerol, in pharmaceutical compositions and growth media |
| 06/28/2007 | US20070149444 Peptides that home to tumor lymphatic vasculature and methods of using same |
| 06/28/2007 | US20070148739 amino acid substitutions at specific positions that confer increased relative activity in biological assays with reduced immunogenic potential in the protein; hepatitis C virus infection |
| 06/28/2007 | US20070148738 comprising bromodomain successfully isolated from a human testis cDNA library using primers prepared based on an EST sequence; for diagnosis and treatment of cancer |
| 06/28/2007 | US20070148737 Materials and Methods For the Purification of Polyelectrolytes, Particularly Nucleic Acids |
| 06/28/2007 | US20070148735 Novel chromophores/fluorophores and methods for using the same |
| 06/28/2007 | US20070148733 Yeast expression vectors for production of ITF |
| 06/28/2007 | US20070148731 Expression control sequence cassette; a nucleotide sequence of a lac operator sequence to which a lacI repressor protein specifically binds a mutated lac; modification of the nucleotide sequence within a T5 promoter/lac operator expression control sequence provides a stable promoter/operator |
| 06/28/2007 | US20070148729 Methods for increasing neisseria protein expression and compositions thereof |
| 06/28/2007 | US20070148728 Recombinantly and transgenically produced glycoproteins; efficient method for enzymatically synthesizing glycoconjugates having the desired fucoylated oligosaccharide moieties |
| 06/28/2007 | US20070148708 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 06/28/2007 | US20070148692 KCNQ potassium channels and methods of modulating same |
| 06/28/2007 | US20070148686 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 06/28/2007 | US20070148682 Protein fragment complementation assays for the detection of biological or drug interactions |
| 06/28/2007 | US20070148673 To generate transgenic, non-human plants or animals or site specific gene modifications in cell lines; fluorescent proteins high through-put screening assays; use as biosensors in prokaryotic and eukaryotic cells, fluorescence activated cell sorting applications, as markers following injection into cells |
| 06/28/2007 | US20070148663 recombinant nucleic acid which when introduced in vivo into a mammalian cell endogenously expressing EB1, inhibits the expression of EB1 therein, thereby reducing the amount of stable microtubules in the cell; antinflammatory agents |
| 06/28/2007 | US20070148662 Prostate-specific membrane antigen |
| 06/28/2007 | US20070148655 Leucine rich repeat containing protein |
| 06/28/2007 | US20070148201 Muteins of a bilin-binding protein with affinity for a given target |
| 06/28/2007 | US20070148189 Stable Liquid Formulations of Botulinum Toxin |
| 06/28/2007 | US20070148188 Anthrax vaccine |
| 06/28/2007 | US20070148184 Survivin-derived peptides and use thereof |
| 06/28/2007 | US20070148183 Chemically programmable immunity |
| 06/28/2007 | US20070148179 Gankyrin |
| 06/28/2007 | US20070148173 Treatment of Acute Lung Injury, Fibrosis and Metastasis with Antagonists of Alpha V Beta 6 |
| 06/28/2007 | US20070148166 Scfvs in photosynthetic microbes |
| 06/28/2007 | US20070148150 MKK7 activation inhibitor |
| 06/28/2007 | US20070148143 Human cytokine receptor |
| 06/28/2007 | US20070148126 comprising a fibronectin type III tenth (10Fn3) domain of 80 to 150 amino acids; Angiogenesis |
| 06/28/2007 | US20070148089 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 06/28/2007 | DE102005061934A1 Method for preparing chemically modified proteins, useful as pharmaceuticals and diagnostic reagents, by protein splicing between two recombinant proteins each comprising an intein and an extein |
| 06/28/2007 | CA2655448A1 Cyclic antimicrobial peptides |
| 06/28/2007 | CA2639624A1 Prognostic prediction method for acute coronary syndrome |
| 06/28/2007 | CA2634911A1 Neisseria meningitidis vaccines and their use |
| 06/28/2007 | CA2634898A1 Immunogenic composition |
| 06/28/2007 | CA2634824A1 Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of muscle relaxation |
| 06/28/2007 | CA2634647A1 Metastin derivatives and use thereof |
| 06/28/2007 | CA2634638A1 A bioassay and peptides for use therein |
| 06/28/2007 | CA2634608A1 Inhibition de la reponse immunitaire anti-fviii |
| 06/28/2007 | CA2634495A1 Process for the production of preformed conjugates of albumin and a therapeutic agent |
| 06/28/2007 | CA2634292A1 Apoptosis-inducing protein complexes and therapeutic use thereof |
| 06/28/2007 | CA2634152A1 Trpa1 inhibitors for treating pain |
| 06/28/2007 | CA2634116A1 Anti-ilt7 antibody |
| 06/28/2007 | CA2633801A1 Cyclodextrin-containing polymers and uses thereof |
| 06/28/2007 | CA2633793A1 Methods of clustering gene and protein sequences |
| 06/28/2007 | CA2633790A1 Methods and compositions for the detection and isolation of ligands |
| 06/28/2007 | CA2633699A1 Mcm6 and mcm7 monoclonal antibodies and methods for their use in the detection of cervical disease |
| 06/28/2007 | CA2633213A1 Soluble gp130 molecule variants useful as a medicament |
| 06/28/2007 | CA2633131A1 Novel cancer-associated antigen |
| 06/28/2007 | CA2632435A1 Soluble il-17rc variant and uses thereof |
| 06/28/2007 | CA2629088A1 Intranasal vaccine for use against disease caused by enterotoxigenic escherichia coli |
| 06/27/2007 | EP1801220A2 Insect-resistant transgenic plants and methods for improving delta-endotoxin activity against insects |
| 06/27/2007 | EP1801219A2 Neisserial antigenic peptides |
| 06/27/2007 | EP1801218A2 Nucleic acids and proteins from streptococcus pneumoniae |
| 06/27/2007 | EP1801217A1 Group A streptococcal vaccines |
| 06/27/2007 | EP1801216A2 Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation |
| 06/27/2007 | EP1801206A1 Method for producing l-arginine, l-ornithine or l-citrulline |
| 06/27/2007 | EP1801124A1 Utilization of sperm membrane protein obf |
| 06/27/2007 | EP1801122A1 Recombinant gelatin particles for cell adhesion |
| 06/27/2007 | EP1801121A1 Soluble gp130 molecule variants useful as a medicament |
| 06/27/2007 | EP1801120A1 Co-crystalline complex of IGF-1 and methods of identifying indirect agonists of IGF-1 using the same |
| 06/27/2007 | EP1801119A1 Interleukin-15 antagonist peptide |
| 06/27/2007 | EP1801118A1 Process for synthesis of mucin-type peptides and muc1-related glycopeptides |
| 06/27/2007 | EP1801117A1 Means and methods for regulating amino acid pools and/or transport |
| 06/27/2007 | EP1801116A1 HCV replicon shuttle vectors |
| 06/27/2007 | EP1800697A2 Pharmaceutical compound, containing a stabilised mRNA which is optimised for translation in its coded areas |
| 06/27/2007 | EP1800691A2 Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| 06/27/2007 | EP1800289A1 Single -pass image warping system and mehtod with anisotropic filtering |
| 06/27/2007 | EP1800131A2 Diagnostics and therapeutics for diseases associated with adrenomedullin receptor (amdr) |
| 06/27/2007 | EP1799868A2 Hcv non-structural protein mutants and uses thereof |
| 06/27/2007 | EP1799866A2 Modulating mxa expression |
| 06/27/2007 | EP1799839A2 Increasing the stability of recombinant adult human apohemoglobin |
| 06/27/2007 | EP1799838A2 Bioactive compositions, natural methods of producing them and computational methods for designing natural production processes |
| 06/27/2007 | EP1799827A2 Fungal transcriptional activators useful in methods for producing a polypeptide |
| 06/27/2007 | EP1799814A1 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof |
| 06/27/2007 | EP1799716A1 Anti-angiogenic peptide |
| 06/27/2007 | EP1799715A1 Thyrotropin receptor preparations, binding regions thereof, antibody and hormone interactions therewith, and uses thereof |
| 06/27/2007 | EP1799714A1 Composition and methods for inhibiting h. pylori adhesion and infection |